Two investigators (HW and TG) independently performed the data extraction from each publication using a standardized form: publication data, baseline characteristics of the study population (sample size, sex, age, body mass index (BMI), body weight, abdominal circumference, waist-to-hip ratio, visceral adipose tissue (measured by computed tomography, magnetic resonance imaging, or dual-emission X-ray absorptiometry)), duration of follow-up, weight change during treatment and after treatment discontinuation, description of the weight management group and control group
Connection Both Ruhoy and Kaufman appear to have glommed onto these drugs via the 700 doctors-plus MASTERMINDS network of health providers in communication with each other about ME/CFS, FM, MCAS, POTS, long COVID, etc
Regular physical activity becomes even more critical during the maintenance phase
Below is an outline of our weight loss program(s)
Efficacy and safety of once-weekly semaglutide versus exenatide ER in subjects with type 2 diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial
